Flinn.ai secures 10 million euros in less than 18 months
The Vienna-based company will use this capital to revolutionize quality management in the medtech sector through AI…
Boehringer Ingelheim expands cancer research at its Vienna site
Inauguration of Angelika Amon research building in Vienna
OeAW and Boehringer Ingelheim Foundation establish new Institute for biomedical artificial intelligence in Vienna
Michael Bronstein leads the new AITHYRA Institute of the Austrian Academy of Sciences
Boehringer Ingelheim Foundation…
Valneva announces the success of its private placement raising approximately €60 million
Not to be released, published, distributed or circulated in the United States, Australia, Japan or any other…
F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and…
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
Ligand also commits to invest up to USD 4 million in APEIRON spin-off, invIOs
Laerdal and SIMCharacters Announce Exclusive Worldwide Distribution Partnership for SIMCharacters Innovative Neonatal Simulation Solutions
Laerdal Medical, a global leader in healthcare simulation solutions, is excited to unveil its exclusive worldwide…
Align Technology completes acquisition of Cubicure, a pioneer of direct 3D printing solutions for polymer additive manufacturing
Align continues to innovate and invest in technologies that enable the next generation of direct 3D printed products,…
Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
- Gilead purchased 15 million newly issued shares of common stock at a price of $1.4167 per share
- Following the close…
Biomay Announces Expansion of its GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
Biomay, a Vienna based biotech manufacturer, announced a facility extension and is now able to expand its…
Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, IXCHIQ®
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug…
HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
- New funds committed to market-ready development of HeartBeat.bio’s unique 3D human tissue-based Cardioid Drug…